Thermo Fisher ups clinical commercial capabilities with $50m investment

Thermo Fisher ups clinical, commercial capabilities with $50m investment

12:32 EDT 25 Apr 2019 | Outsourcing-Pharma

Thermo Fisher Scientific is investing $50m to further expand its biologic drug substance capabilities for both clinical and commercial supply.

Original Article: Thermo Fisher ups clinical, commercial capabilities with $50m investment

More From BioPortfolio on "Thermo Fisher ups clinical, commercial capabilities with $50m investment"